SYK
Stryker Corporation
NYSE · USHealthcareMedical - Devices
$319.14-0.23%
Price as of Jul 20, 2026
SYK profitability
Stryker Corporation profitability
Margins, returns on capital and operating-efficiency metrics from the latest trailing period.
Margins
- Gross margin
- 63.7%
- EBITDA margin
- 24.4%
- EBIT margin
- 21.3%
- Net margin
- 13.2%
- Free cash flow margin
- 18.1%
Returns
- Return on equity
- 14.5%
- Return on assets
- 7.2%
- Return on invested capital
- 14.1%
- Asset turnover
- 0.54x
Cash efficiency
- Cash from operations
- $5.4B
- Cash per share
- $7.73
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.